Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE0005659700
Mon, 17.05.2021
Eckert & Ziegler Strahlen- und Medizintechnik AG
Berlin, 17 May 2021. One-off effects from the deconsolidation of the tumor irradiation business, a waning of the Corona slump, and continued strong demand in particular for pharmaceutical radioisotopes more than doubled net profit at Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700; TecDAX) in the first quarter of 2021. With [ … ]
Wed, 28.04.2021
Eckert & Ziegler Strahlen- und Medizintechnik AG
Berlin, 28 April 2021. Eckert & Ziegler AG (ISIN DE0005659700, TecDAX) and Sirtex Medical (Sirtex) have executed a long-term supply agreement for the use of EZAG's Yttrium-90 in Sirtex SIR-Spheres(R) Y-90 resin microspheres for liver cancer. The arrangement has an initial term of five years and guarantees Eckert & Ziegler a substantial shar [ … ]
Fri, 16.04.2021
Eckert & Ziegler Strahlen- und Medizintechnik AG
Berlin, 16 April 2021 - Eckert & Ziegler Strahlen- und Medizintechnik AG today acquired several share packages from the founders of the drug developer PENTIXAPHARM GmbH. Together with another internal share transfer, Eckert & Ziegler AG will directly hold a total of about 83% of the shares in the Würzburg-based company as of closing of the [ … ]
Wed, 14.04.2021
Eckert & Ziegler Strahlen- und Medizintechnik AG
Berlin, 14 April 2021. Eckert & Ziegler is proud to announce that it is expanding its production site in Berlin, Germany, with a new production facility for the contract manufacturing of radiopharmaceuticals. This new cGMP clean room suite with a total area of around 270 m² will be a 21 CFR 211 compliant, radiopharmaceutical manufacturing facil [ … ]
Mon, 12.04.2021
Eckert & Ziegler Strahlen- und Medizintechnik AG
Sao Paulo, 12 April 2021 - The Brazilian regulator ANVISA has provided Eckert & Ziegler Brasil Comercial Ltda., a fully owned subsidiary of Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX), with a license to import and distribute technetium generators. This is the second license ever given to an organization in B [ … ]
Tue, 12.01.2021
Eckert & Ziegler Strahlen- und Medizintechnik AG
Berlin, 12 January 2021. Seed implantation for prostate cancer is now to be reimbursed as an outpatient treatment by public health insurances in Germany. This was decided by the Federal Joint Committee (G-BA) with effect from January 8, 2021.
Seed implantation or so called LDR brachytherapy is an organ-preserving, minimally invasive radiation proc [ … ]
Tue, 10.11.2020
Eckert & Ziegler Strahlen- und Medizintechnik AG
Berlin, 10 November 2020. Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX), a specialist for isotope applications in medicine, science and industry, again achieved a very strong result of EUR 17.7 million in the first nine months of 2020. Compared to the same period of the previous year, consolidated net income decre [ … ]
Fri, 18.09.2020
Eckert & Ziegler Strahlen- und Medizintechnik AG
Berlin, 18 September 2020. Eckert & Ziegler Strahlen- und Medizintechnik AG (EZAG) plans to run its business with tumor radiation equipment together with TCL Healthcare Equipment (Shanghai) Co., Ltd. (TCL). The two companies today signed a binding letter of intent under which EZAG will transfer its division with the so-called afterloaders (HDR [ … ]
Tue, 25.08.2020
Eckert & Ziegler Strahlen- und Medizintechnik AG
Berlin, 25 August 2020. Eckert & Ziegler Radiopharma GmbH has received approval for its pharmaceutical 68Ge/68Ga generator GalliaPharm(R) from the Canadian regulatory authority Health Canada.
"We are pleased to now be able to offer GalliaPharm(R) in Canada. Meanwhile, the generators from Eckert & Ziegler are available in more and more coun [ … ]
Thu, 13.08.2020
Eckert & Ziegler Strahlen- und Medizintechnik AG
Berlin, 13 August 2020. Despite heavy burdens from corona and the drop in oil price, Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX), a specialist for isotope applications in medicine, science and industry, closed the first half of 2020 with a net income of 12.7 million EUR, almost reaching the record level of the p [ … ]